Everolimus: preventing organ rejection in adult kidney transplant recipients.
about
Everolimus for subependymal giant cell astrocytoma: 5-year final analysis.An evaluation of sirolimus in renal transplantation.Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation.Natural products as probes in pharmaceutical research.Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
P2860
Everolimus: preventing organ rejection in adult kidney transplant recipients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Everolimus: preventing organ rejection in adult kidney transplant recipients.
@en
Everolimus: preventing organ rejection in adult kidney transplant recipients.
@nl
type
label
Everolimus: preventing organ rejection in adult kidney transplant recipients.
@en
Everolimus: preventing organ rejection in adult kidney transplant recipients.
@nl
prefLabel
Everolimus: preventing organ rejection in adult kidney transplant recipients.
@en
Everolimus: preventing organ rejection in adult kidney transplant recipients.
@nl
P2860
P1476
Everolimus: preventing organ rejection in adult kidney transplant recipients.
@en
P2093
Jacques Dantal
P2860
P304
P356
10.1517/14656566.2012.662955
P407
P577
2012-03-12T00:00:00Z